Structure

Physi-Chem Properties

Molecular Weight:  378.11
Volume:  375.299
LogP:  4.627
LogD:  3.723
LogS:  -5.664
# Rotatable Bonds:  2
TPSA:  67.13
# H-Bond Aceptor:  6
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  6

MedChem Properties

QED Drug-Likeness Score:  0.659
Synthetic Accessibility Score:  2.9
Fsp3:  0.227
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.988
MDCK Permeability:  2.9256783818709664e-05
Pgp-inhibitor:  0.994
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.003
20% Bioavailability (F20%):  0.022
30% Bioavailability (F30%):  0.032

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.024
Plasma Protein Binding (PPB):  96.3164291381836%
Volume Distribution (VD):  0.321
Pgp-substrate:  4.195736885070801%

ADMET: Metabolism

CYP1A2-inhibitor:  0.9
CYP1A2-substrate:  0.353
CYP2C19-inhibitor:  0.967
CYP2C19-substrate:  0.107
CYP2C9-inhibitor:  0.906
CYP2C9-substrate:  0.913
CYP2D6-inhibitor:  0.899
CYP2D6-substrate:  0.889
CYP3A4-inhibitor:  0.942
CYP3A4-substrate:  0.21

ADMET: Excretion

Clearance (CL):  8.576
Half-life (T1/2):  0.158

ADMET: Toxicity

hERG Blockers:  0.025
Human Hepatotoxicity (H-HT):  0.896
Drug-inuced Liver Injury (DILI):  0.905
AMES Toxicity:  0.2
Rat Oral Acute Toxicity:  0.202
Maximum Recommended Daily Dose:  0.557
Skin Sensitization:  0.166
Carcinogencity:  0.938
Eye Corrosion:  0.003
Eye Irritation:  0.025
Respiratory Toxicity:  0.927

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC273021

Natural Product ID:  NPC273021
Common Name*:   Jamaicin
IUPAC Name:   3-(6-methoxy-1,3-benzodioxol-5-yl)-8,8-dimethylpyrano[2,3-f]chromen-4-one
Synonyms:  
Standard InCHIKey:  WITLAWYGGVAFLU-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C22H18O6/c1-22(2)7-6-12-16(28-22)5-4-13-20(23)15(10-25-21(12)13)14-8-18-19(27-11-26-18)9-17(14)24-3/h4-10H,11H2,1-3H3
SMILES:  CC1(C)C=Cc2c(ccc3c(=O)c(coc23)c2cc3c(cc2OC)OCO3)O1
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3758966
PubChem CID:   12304682
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0002506] Isoflavonoids
        • [CHEMONTID:0003530] Pyranoisoflavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO29483 Swartzia schomburgkii Species Fabaceae Eukaryota n.a. suriname rainforest n.a. PMID[11087583]
NPO28682 Jatropha multifida Species Euphorbiaceae Eukaryota n.a. n.a. n.a. PMID[19036584]
NPO28682 Jatropha multifida Species Euphorbiaceae Eukaryota stems Botanical Garden, Osmania University, Hyderabad, Andhra Pradesh 2006-AUG PMID[21534583]
NPO28626 Isodon rubescens Species Lamiaceae Eukaryota n.a. n.a. n.a. PMID[25590529]
NPO448 Millettia usaramensis Species Fabaceae Eukaryota n.a. n.a. n.a. PMID[26651537]
NPO29252 Moneses uniflora Species Ericaceae Eukaryota n.a. n.a. n.a. PMID[8984155]
NPO29132 Agaricus campestris Species Agaricaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28711 Artabotrys hexapetalus Species Annonaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO28626 Isodon rubescens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28711 Artabotrys hexapetalus Species Annonaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO29132 Agaricus campestris Species Agaricaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO448 Millettia usaramensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28711 Artabotrys hexapetalus Species Annonaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO29132 Agaricus campestris Species Agaricaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO28626 Isodon rubescens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28767 Siparuna apiosyce Species Siparunaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28626 Isodon rubescens Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29483 Swartzia schomburgkii Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29132 Agaricus campestris Species Agaricaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29288 Diplorhynchus condylocarpon Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29393 Hapalopilus rutilans Species Phanerochaetaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29339 Didemnum moseleyi Species Didemnidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29269 Celsia roripifolia Species Scrophulariaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28728 Scutellaria planipes Species Lamiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28664 Hydrangea arborescens Species Hydrangeaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO448 Millettia usaramensis Species Fabaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28699 Vincetoxicum nigrum Species Apocynaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28798 Calophyllum macrocarpum Species Calophyllaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29022 Sarcococca wallichii Species Buxaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28711 Artabotrys hexapetalus Species Annonaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29252 Moneses uniflora Species Ericaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28910 Dacus cucumis Species Tephritidae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28682 Jatropha multifida Species Euphorbiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO28606 Lemaireocereus thurberi Species Cactaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO29164 Lophostemon confertus Species Myrtaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT757 Organism Plasmodium falciparum 3D7 Plasmodium falciparum 3D7 Inhibition = 94.0 % PMID[528196]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum Inhibition = 81.0 % PMID[528196]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC273021 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC18284
0.9675 High Similarity NPC113055
0.9551 High Similarity NPC34376
0.9542 High Similarity NPC128961
0.949 High Similarity NPC302741
0.9484 High Similarity NPC19097
0.9484 High Similarity NPC310206
0.9481 High Similarity NPC478238
0.9419 High Similarity NPC180340
0.9416 High Similarity NPC478213
0.9416 High Similarity NPC472408
0.9412 High Similarity NPC279061
0.9359 High Similarity NPC258644
0.9351 High Similarity NPC148497
0.9351 High Similarity NPC52623
0.9351 High Similarity NPC292460
0.9351 High Similarity NPC166201
0.9351 High Similarity NPC68882
0.9351 High Similarity NPC153008
0.9321 High Similarity NPC475825
0.9321 High Similarity NPC223375
0.9295 High Similarity NPC155063
0.929 High Similarity NPC57211
0.929 High Similarity NPC244371
0.9245 High Similarity NPC478199
0.9221 High Similarity NPC5840
0.9221 High Similarity NPC189270
0.9212 High Similarity NPC67302
0.9198 High Similarity NPC471287
0.9182 High Similarity NPC94155
0.9177 High Similarity NPC257914
0.9177 High Similarity NPC238405
0.9177 High Similarity NPC104459
0.9152 High Similarity NPC156635
0.9125 High Similarity NPC261470
0.9119 High Similarity NPC298093
0.9108 High Similarity NPC284353
0.9103 High Similarity NPC40033
0.9074 High Similarity NPC113093
0.9062 High Similarity NPC40037
0.9062 High Similarity NPC165549
0.9057 High Similarity NPC215375
0.9057 High Similarity NPC62518
0.9051 High Similarity NPC248299
0.9045 High Similarity NPC279930
0.9045 High Similarity NPC186507
0.903 High Similarity NPC72455
0.9026 High Similarity NPC205522
0.9018 High Similarity NPC471288
0.9018 High Similarity NPC135345
0.9012 High Similarity NPC50960
0.9012 High Similarity NPC470773
0.9006 High Similarity NPC125991
0.9 High Similarity NPC131557
0.8994 High Similarity NPC476981
0.8994 High Similarity NPC167595
0.8981 High Similarity NPC144162
0.8976 High Similarity NPC472607
0.8968 High Similarity NPC63256
0.8968 High Similarity NPC10304
0.8963 High Similarity NPC41853
0.8961 High Similarity NPC40818
0.8961 High Similarity NPC216314
0.8961 High Similarity NPC120924
0.8961 High Similarity NPC106461
0.8961 High Similarity NPC110639
0.8961 High Similarity NPC195919
0.8961 High Similarity NPC14958
0.8961 High Similarity NPC215932
0.8957 High Similarity NPC173292
0.8954 High Similarity NPC182842
0.8951 High Similarity NPC65846
0.8944 High Similarity NPC259456
0.8944 High Similarity NPC260640
0.8944 High Similarity NPC295009
0.8935 High Similarity NPC473883
0.8922 High Similarity NPC257714
0.891 High Similarity NPC238366
0.8909 High Similarity NPC472276
0.8909 High Similarity NPC105511
0.8903 High Similarity NPC85233
0.8902 High Similarity NPC167479
0.8896 High Similarity NPC296575
0.8896 High Similarity NPC471590
0.8896 High Similarity NPC136278
0.8896 High Similarity NPC224687
0.8896 High Similarity NPC165512
0.8896 High Similarity NPC475369
0.8889 High Similarity NPC81679
0.8889 High Similarity NPC472448
0.8889 High Similarity NPC83922
0.8889 High Similarity NPC469575
0.8882 High Similarity NPC476980
0.8882 High Similarity NPC225624
0.8882 High Similarity NPC285973
0.8875 High Similarity NPC78071
0.8862 High Similarity NPC66804
0.8855 High Similarity NPC48773
0.8855 High Similarity NPC205076
0.8855 High Similarity NPC307518
0.8855 High Similarity NPC475155
0.8855 High Similarity NPC235575
0.8848 High Similarity NPC152477
0.8848 High Similarity NPC211309
0.8848 High Similarity NPC242395
0.8846 High Similarity NPC476342
0.8841 High Similarity NPC128293
0.8839 High Similarity NPC302408
0.8839 High Similarity NPC231013
0.8839 High Similarity NPC283002
0.8834 High Similarity NPC470178
0.8834 High Similarity NPC470772
0.8831 High Similarity NPC113089
0.8831 High Similarity NPC23955
0.8827 High Similarity NPC162668
0.8827 High Similarity NPC167678
0.8827 High Similarity NPC29876
0.8827 High Similarity NPC470756
0.882 High Similarity NPC184755
0.882 High Similarity NPC187792
0.882 High Similarity NPC74178
0.8805 High Similarity NPC280937
0.8802 High Similarity NPC62640
0.8802 High Similarity NPC310794
0.8797 High Similarity NPC198615
0.8795 High Similarity NPC44558
0.8795 High Similarity NPC212748
0.8795 High Similarity NPC474434
0.8795 High Similarity NPC224462
0.879 High Similarity NPC69752
0.8788 High Similarity NPC8965
0.8788 High Similarity NPC76482
0.8788 High Similarity NPC93099
0.878 High Similarity NPC187923
0.8773 High Similarity NPC229632
0.8766 High Similarity NPC9966
0.8766 High Similarity NPC476054
0.8766 High Similarity NPC70853
0.8765 High Similarity NPC204290
0.8765 High Similarity NPC43971
0.8765 High Similarity NPC19554
0.8765 High Similarity NPC74749
0.8765 High Similarity NPC269906
0.8765 High Similarity NPC328102
0.8758 High Similarity NPC473272
0.8758 High Similarity NPC284820
0.8757 High Similarity NPC168584
0.8743 High Similarity NPC121333
0.8742 High Similarity NPC35544
0.8742 High Similarity NPC104728
0.8735 High Similarity NPC58053
0.8735 High Similarity NPC477165
0.8735 High Similarity NPC226294
0.8735 High Similarity NPC186807
0.8735 High Similarity NPC183036
0.8735 High Similarity NPC469931
0.8735 High Similarity NPC93337
0.8735 High Similarity NPC45638
0.8735 High Similarity NPC95855
0.8735 High Similarity NPC288813
0.8735 High Similarity NPC472383
0.8735 High Similarity NPC105025
0.8735 High Similarity NPC475942
0.8735 High Similarity NPC210042
0.8735 High Similarity NPC201292
0.8735 High Similarity NPC472381
0.8734 High Similarity NPC201547
0.8734 High Similarity NPC29056
0.8734 High Similarity NPC259058
0.8727 High Similarity NPC67450
0.8727 High Similarity NPC120593
0.8727 High Similarity NPC210460
0.8727 High Similarity NPC155264
0.8727 High Similarity NPC193881
0.872 High Similarity NPC303460
0.872 High Similarity NPC124038
0.872 High Similarity NPC273959
0.872 High Similarity NPC306321
0.8712 High Similarity NPC198829
0.8712 High Similarity NPC182045
0.8712 High Similarity NPC258331
0.8712 High Similarity NPC471290
0.871 High Similarity NPC293201
0.8704 High Similarity NPC204879
0.8701 High Similarity NPC214919
0.8701 High Similarity NPC29536
0.8701 High Similarity NPC185607
0.8701 High Similarity NPC124467
0.8696 High Similarity NPC276444
0.8696 High Similarity NPC303255
0.8696 High Similarity NPC282307
0.8696 High Similarity NPC472455
0.8696 High Similarity NPC170026
0.8696 High Similarity NPC301897
0.8696 High Similarity NPC471985
0.8688 High Similarity NPC472915
0.8688 High Similarity NPC168805
0.8688 High Similarity NPC121910
0.8683 High Similarity NPC34287
0.8683 High Similarity NPC21190

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC273021 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9119 High Similarity NPD5494 Approved
0.8788 High Similarity NPD3818 Discontinued
0.8598 High Similarity NPD1247 Approved
0.8571 High Similarity NPD2801 Approved
0.8428 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.8421 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.8405 Intermediate Similarity NPD3817 Phase 2
0.8402 Intermediate Similarity NPD7054 Approved
0.8364 Intermediate Similarity NPD919 Approved
0.8354 Intermediate Similarity NPD3882 Suspended
0.8353 Intermediate Similarity NPD7074 Phase 3
0.8353 Intermediate Similarity NPD7472 Approved
0.8344 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8303 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8282 Intermediate Similarity NPD1934 Approved
0.8258 Intermediate Similarity NPD2796 Approved
0.8208 Intermediate Similarity NPD7808 Phase 3
0.8199 Intermediate Similarity NPD920 Approved
0.8198 Intermediate Similarity NPD6797 Phase 2
0.815 Intermediate Similarity NPD7251 Discontinued
0.8081 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8081 Intermediate Similarity NPD5844 Phase 1
0.8075 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8072 Intermediate Similarity NPD5402 Approved
0.8061 Intermediate Similarity NPD6801 Discontinued
0.8059 Intermediate Similarity NPD3926 Phase 2
0.8049 Intermediate Similarity NPD4380 Phase 2
0.8046 Intermediate Similarity NPD6559 Discontinued
0.8012 Intermediate Similarity NPD1511 Approved
0.8012 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD7819 Suspended
0.8012 Intermediate Similarity NPD6166 Phase 2
0.8012 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7963 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7917 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7914 Intermediate Similarity NPD1512 Approved
0.7901 Intermediate Similarity NPD6799 Approved
0.7895 Intermediate Similarity NPD6232 Discontinued
0.7892 Intermediate Similarity NPD7411 Suspended
0.7875 Intermediate Similarity NPD1243 Approved
0.787 Intermediate Similarity NPD7075 Discontinued
0.7861 Intermediate Similarity NPD7473 Discontinued
0.784 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD1933 Approved
0.7736 Intermediate Similarity NPD1510 Phase 2
0.7733 Intermediate Similarity NPD7199 Phase 2
0.7725 Intermediate Similarity NPD6599 Discontinued
0.7702 Intermediate Similarity NPD1549 Phase 2
0.7683 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD5403 Approved
0.765 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7647 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7637 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7636 Intermediate Similarity NPD5401 Approved
0.7633 Intermediate Similarity NPD37 Approved
0.763 Intermediate Similarity NPD6959 Discontinued
0.7625 Intermediate Similarity NPD3748 Approved
0.7602 Intermediate Similarity NPD4967 Phase 2
0.7602 Intermediate Similarity NPD4965 Approved
0.7602 Intermediate Similarity NPD4966 Approved
0.7588 Intermediate Similarity NPD1465 Phase 2
0.7578 Intermediate Similarity NPD2935 Discontinued
0.7569 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7558 Intermediate Similarity NPD3749 Approved
0.7546 Intermediate Similarity NPD2800 Approved
0.753 Intermediate Similarity NPD2532 Approved
0.753 Intermediate Similarity NPD2534 Approved
0.753 Intermediate Similarity NPD2533 Approved
0.7514 Intermediate Similarity NPD6234 Discontinued
0.7514 Intermediate Similarity NPD3751 Discontinued
0.75 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD7768 Phase 2
0.7486 Intermediate Similarity NPD3787 Discontinued
0.7486 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7484 Intermediate Similarity NPD1240 Approved
0.7439 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7396 Intermediate Similarity NPD1653 Approved
0.7394 Intermediate Similarity NPD3750 Approved
0.7394 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7391 Intermediate Similarity NPD1607 Approved
0.7368 Intermediate Similarity NPD6777 Approved
0.7368 Intermediate Similarity NPD6780 Approved
0.7368 Intermediate Similarity NPD6776 Approved
0.7368 Intermediate Similarity NPD6778 Approved
0.7368 Intermediate Similarity NPD6782 Approved
0.7368 Intermediate Similarity NPD6781 Approved
0.7368 Intermediate Similarity NPD6779 Approved
0.7358 Intermediate Similarity NPD2313 Discontinued
0.7348 Intermediate Similarity NPD7685 Pre-registration
0.7345 Intermediate Similarity NPD5242 Approved
0.7329 Intermediate Similarity NPD447 Suspended
0.7318 Intermediate Similarity NPD7228 Approved
0.7303 Intermediate Similarity NPD2403 Approved
0.7301 Intermediate Similarity NPD2799 Discontinued
0.7278 Intermediate Similarity NPD7286 Phase 2
0.7273 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD8312 Approved
0.7268 Intermediate Similarity NPD8313 Approved
0.7267 Intermediate Similarity NPD943 Approved
0.7254 Intermediate Similarity NPD7435 Discontinued
0.7254 Intermediate Similarity NPD7696 Phase 3
0.7254 Intermediate Similarity NPD7698 Approved
0.7254 Intermediate Similarity NPD7697 Approved
0.7251 Intermediate Similarity NPD7458 Discontinued
0.7251 Intermediate Similarity NPD3226 Approved
0.725 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7233 Intermediate Similarity NPD6832 Phase 2
0.7231 Intermediate Similarity NPD7584 Approved
0.7222 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD7870 Phase 2
0.7216 Intermediate Similarity NPD7871 Phase 2
0.7215 Intermediate Similarity NPD2798 Approved
0.7213 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7212 Intermediate Similarity NPD2346 Discontinued
0.7202 Intermediate Similarity NPD5005 Approved
0.7202 Intermediate Similarity NPD5006 Approved
0.7198 Intermediate Similarity NPD5953 Discontinued
0.7188 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6385 Approved
0.7168 Intermediate Similarity NPD6386 Approved
0.7158 Intermediate Similarity NPD7240 Approved
0.7152 Intermediate Similarity NPD1551 Phase 2
0.7151 Intermediate Similarity NPD8434 Phase 2
0.7143 Intermediate Similarity NPD5353 Approved
0.7117 Intermediate Similarity NPD230 Phase 1
0.7115 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7113 Intermediate Similarity NPD6823 Phase 2
0.7111 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7108 Intermediate Similarity NPD2344 Approved
0.7107 Intermediate Similarity NPD7701 Phase 2
0.7105 Intermediate Similarity NPD6534 Approved
0.7105 Intermediate Similarity NPD6535 Approved
0.7095 Intermediate Similarity NPD7229 Phase 3
0.7085 Intermediate Similarity NPD7783 Phase 2
0.7085 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD4628 Phase 3
0.7083 Intermediate Similarity NPD4420 Approved
0.7071 Intermediate Similarity NPD8151 Discontinued
0.7035 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7035 Intermediate Similarity NPD7874 Approved
0.7033 Intermediate Similarity NPD7893 Clinical (unspecified phase)
0.7029 Intermediate Similarity NPD6844 Discontinued
0.7024 Intermediate Similarity NPD2654 Approved
0.7011 Intermediate Similarity NPD7028 Phase 2
0.7006 Intermediate Similarity NPD5019 Clinical (unspecified phase)
0.7006 Intermediate Similarity NPD3705 Approved
0.7006 Intermediate Similarity NPD1471 Phase 3
0.7 Intermediate Similarity NPD5710 Approved
0.7 Intermediate Similarity NPD5711 Approved
0.7 Intermediate Similarity NPD7801 Approved
0.6995 Remote Similarity NPD7699 Phase 2
0.6995 Remote Similarity NPD7700 Phase 2
0.6989 Remote Similarity NPD8455 Phase 2
0.6988 Remote Similarity NPD7033 Discontinued
0.6988 Remote Similarity NPD1509 Clinical (unspecified phase)
0.6971 Remote Similarity NPD5890 Approved
0.6971 Remote Similarity NPD5889 Approved
0.697 Remote Similarity NPD6651 Approved
0.6951 Remote Similarity NPD1613 Approved
0.6951 Remote Similarity NPD4307 Phase 2
0.6951 Remote Similarity NPD1612 Clinical (unspecified phase)
0.6943 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6941 Remote Similarity NPD6190 Approved
0.6941 Remote Similarity NPD2309 Approved
0.6935 Remote Similarity NPD7549 Discontinued
0.6914 Remote Similarity NPD1529 Clinical (unspecified phase)
0.6914 Remote Similarity NPD6585 Discontinued
0.6909 Remote Similarity NPD5124 Phase 1
0.6909 Remote Similarity NPD5123 Clinical (unspecified phase)
0.6905 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6903 Remote Similarity NPD5536 Phase 2
0.6884 Remote Similarity NPD7583 Approved
0.6882 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6878 Remote Similarity NPD8150 Discontinued
0.6872 Remote Similarity NPD8285 Discontinued
0.6871 Remote Similarity NPD3027 Phase 3
0.686 Remote Similarity NPD7390 Discontinued
0.6852 Remote Similarity NPD1530 Clinical (unspecified phase)
0.6851 Remote Similarity NPD8127 Discontinued
0.685 Remote Similarity NPD7585 Approved
0.6845 Remote Similarity NPD6099 Approved
0.6845 Remote Similarity NPD6100 Approved
0.6842 Remote Similarity NPD3887 Approved
0.6839 Remote Similarity NPD4363 Phase 3
0.6839 Remote Similarity NPD4360 Phase 2
0.6836 Remote Similarity NPD6280 Approved
0.6836 Remote Similarity NPD6279 Approved
0.6833 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6832 Remote Similarity NPD3266 Approved
0.6832 Remote Similarity NPD3267 Approved
0.6829 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6824 Remote Similarity NPD6674 Discontinued
0.6821 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6813 Remote Similarity NPD6808 Phase 2
0.6804 Remote Similarity NPD4362 Clinical (unspecified phase)

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data